News
FDA rushed out agency-wide AI tool—it’s not going well
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't connected to the Internet or the FDA's internal system, and has problems uploading documents and allowing users to submit questions.
Startup Clairity scored a greenlight from the FDA for the agency's first artificial intelligence tool designed to predict ...
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its ...
The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...
The FDA is moving quickly to bring artificial intelligence (AI) into the heart of its regulatory review process. On May 8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback